Anocca To Reach Clinical-Stage With T-Cell Therapies After Series B Injection

Swedish Biotech Developing Pipeline Of TCR-T Cellular Therapies

Anocca’s varied and wide-ranging TCR-T pipeline will now progress to clinic • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D